Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
-
Shares outstanding
-
62,650,155
-
Total 13F shares
-
26,711
-
Share change
-
-48,841,874
-
Total reported value
-
$493,982
-
Price per share
-
$8.84
-
Number of holders
-
4
-
Value change
-
-$445,436,977
-
Number of buys
-
1
-
Number of sells
-
185
Institutional Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q3 2025
As of 30 Sep 2025,
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) was held by
4 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,711 shares.
The largest 4 holders included
DekaBank Deutsche Girozentrale, OSAIC HOLDINGS, INC., IFP Advisors, Inc, and HUNTINGTON NATIONAL BANK.
This page lists
4
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.